Cholesterol Pill Taken by Thousands Causes Cancer
September 09, 2008
Spread the Word to
Friends And Family
By Sharing this Article.
A pill intended to lower cholesterol levels has been linked to an increased risk of cancer.
The U.S. Food and Drug Administration is reviewing data from a trial which found a “larger percentage” of patients treated with the drug Inegy died of cancer. The FDA is expected to issue its conclusions within six months.
Inegy combines the widely-used statin drug simvastatin with a new medication called ezetimibe. Ezetimibe works in a different way from statins. Statins block cholesterol made in the liver, while ezetimibe blocks the absorption of cholesterol in the gut.
Stay Up-To-Date on the Latest Health News
If you haven't already, here's your chance to subscribe to the world's most popular newsletter! My FREE newsletter is instrumental in changing the lives of many people across the world. If you want to take control of your health then you won't want to miss out on this opportunity.
When you subscribe I guarantee:
- You'll be the first to hear about fast-breaking health news and hard-to-find tips for improving your emotional, physical, and spiritual well-being
- You'll save money because I'm committed to helping you stay healthy, so you won't need expensive prescription drugs or doctor's visits so often
- You'll get straight talk from me in plain English that shatters all the myths and misconceptions about health, aging, and fitness
Don't be left in the dark on breaking health news! Sign up for my daily newsletter today!